June 20, 2007 — Sono-Tek Corporation recently announced the release of the MediCoat PSI.
The MediCoat PSI offers the ...
This channel includes news and new technology innovations for drug eluting stents (DES). These drug coated stents were developed to solve a frequent problem with bare metal stents, which can cause neointimal hyperplasia (scar tissue growth) in some patients. The antiproliferative drugs used on DES prevent the growth of tissue. One downside of DES is the requirement for patients to take long-term antiplatelet therapy to prevent the possible formation of clots on these stents. Newer generation DES use technologies help the vessels heal faster, which may allow reduce the duration of dual antiplatelet therapy (DAPT), or use a single drug, usually eliminating aspirin. This section includes news for both metallic and bioresorbable drug-eluting stents and related clinical trial data.
June 20, 2007 — Sono-Tek Corporation recently announced the release of the MediCoat PSI.
The MediCoat PSI offers the ...
June 15, 2007 — Johnson & Johnson says U.S. regulators have ended almost three years of sanctions over manufacturing ...
June 1, 2007 — Abbott announced it has completed its application to the U.S. Food and Drug Administration (FDA) ...
May 30, 2007 -- As concern and investigation continue concerning the link between drug-eluting stents and late-stent ...
May 29, 2007 — Stentys says the results of preclinical testing of its bifurcated stent were reported at last week's ...
May 29, 2007 — Medtronic Inc. has enrolled the first patient in the landmark PROTECT clinical study, the largest ...
May 29, 2007 — Boston Scientific Corp. has received CE Mark for its TAXUS Liberte Long paclitaxel-eluting coronary stent ...
May 29, 2007 — Abbott announced positive results last week from ABSORB, the world’s first clinical trial evaluating the ...
May 23, 2007 — XTENT Inc. announced positive six-month follow-up data from the CUSTOM II clinical trial, which assessed ...
May 18, 2007 — According to a report published Thursday in the Wall Street Journal and posted on UPI, the number of ...
May 16, 2007 — Stentys has announced that the results of preclinical testing of its bifurcated stent will be reported on ...
May 16, 2007 — Boston Scientific Corp. has announced that it has completed enrollment in the European and ...
May 14, 2007 — Two renowned experts debated the role of PCI and coronary artery bypass grafting (CABG) for the treatment ...
May 14, 2007 — More than 25 leading heart advocacy groups have joined to form the Sudden Cardiac Arrest (SCA) Coalition ...
May 11, 2007 — Northwestern University in Chicago has published results of a one-year study of roughly 5,500 patients ...